Couchbase, maker of a nonSQL database, has confidentially filed a registration statement with the US Securities and Exchange Commission to go public in a deal it hopes will value the company at $3 billion.
We will update this page as new information becomes available.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $16.75 |
|---|---|
| 52-week range | $11.68 - $52.26 |
| 50-day moving average | $15.32 |
| 200-day moving average | $23.71 |
| Wall St. target price | $21.25 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-1.84 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $16.75 from 2022-07-01
| 1 week (2022-06-28) | 0.90% |
|---|---|
| 1 month (2022-06-06) | 19.13% |
| 3 months (2022-04-06) | -2.10% |
| 6 months (2022-01-06) | -19.66% |
| 1 year (2021-07-06) | -43.72% |
|---|---|
| 2 years (2020-07-02) | N/A |
| 3 years (2019-07-05) | 20.52 |
| 5 years (2017-07-02) | N/A |
| Revenue TTM | $130.4 million |
|---|---|
| Gross profit TTM | $108.8 million |
| Return on assets TTM | -20.95% |
| Return on equity TTM | -71.94% |
| Profit margin | -48.65% |
| Book value | $3.98 |
| Market capitalisation | $746.2 million |
TTM: trailing 12 months
We're not expecting Couchbase to pay a dividend over the next 12 months.
You may also wish to consider:
Couchbase, Inc. provides a database for enterprise applications worldwide. Its database works in multiple configurations, ranging from cloud to multi- or hybrid-cloud to on-premise environments to the edge. The company offers Couchbase Server, a multi-service NoSQL database, which provides SQL-compatible query language and SQL++, that allows for a various array of data manipulation functions; and Couchbase Capella, an automated and secure Database-as-a-Service that helps in database management by deploying, managing, and operating Couchbase Server across cloud environments. It also provides Couchbase Mobile, an embedded NoSQL database for mobile and edge devices that enables an always-on experience with high data availability, even without internet connectivity, as well as synchronization gateway that allows for secure data sync between mobile devices and the backend data store. The company sells its platform through direct sales force and an ecosystem of partners. It servs governments and organizations, as well as enterprises in various industries, including retail and e-commerce, travel and hospitality, financial services and insurance, software and technology, gaming, media and entertainment, and industrials.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.